Nosca-Méréprine (Noscapine Hydrochloride)

Noscapine Hydrochloride, the active ingredient in Nosca-Méréprine, is an antitussive presented as an oral formulation for oral use. It is employed to suppress coughs in adults and provides symptomatic relief for non‑productive coughs.

GNH USA supplies Nosca-Méréprine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Noscapine Hydrochloride is used as an antitussive to suppress coughs originating from the respiratory tract.

- Acute cough: reduces frequency and intensity of sudden, non‑productive cough episodes. - Chronic cough: provides symptomatic relief when used under medical supervision for persistent cough. - Cough associated with bronchitis: helps alleviate irritating cough during upper respiratory infections.

Adverse reactions to Nosca-Méréprine are generally mild, but patients should be aware of possible side effects.

Common Side Effects: - Drowsiness: mild sedation reported in some users. - Nausea: occasional gastrointestinal upset. - Dizziness: transient light‑headedness. - Headache: mild to moderate intensity. - Rash: mild skin irritation. - Gastrointestinal discomfort: mild abdominal pain or dyspepsia.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Stevens‑Johnson syndrome: rare severe skin eruption. - Hepatic dysfunction: abnormal liver enzymes or jaundice. - Neutropenia: reduced white blood cell count. - Seizures: extremely rare central nervous system event. - Severe hypersensitivity: swelling of face, lips, or throat.

Before using Nosca-Méréprine, consider the following safety measures.

- Use in children: follow prescriber guidance and age‑appropriate dosing. - Pregnancy: safety category unknown; avoid unless clearly needed. - Breastfeeding: unknown excretion; weigh benefits against potential risks. - Concomitant CNS depressants: may increase sedation; monitor closely. - Hepatic or renal impairment: consider dose adjustment or alternative therapy. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Nosca-Méréprine may interact with other medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Opioid analgesics: additive CNS depression may increase sedation. - Alcohol: enhances drowsiness and impairs coordination. - Antihistamines: may potentiate sedation and dizziness.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): monitor for increased CNS effects. - Anticonvulsants: possible alteration of seizure threshold. - Anticholinergic agents: watch for enhanced anticholinergic side effects such as dry mouth or blurred vision.